CXXIF Stock Chart & Stats
$0.33
>-$0.01(-0.80%)
At close: 4:00 PM EST
$0.33
>-$0.01(-0.80%)
Day’s Range― - ―
52-Week Range$0.15 - $0.54
Previous CloseN/A
Volume26.10K
Average Volume (3M)152.34K
Market Cap
$53.94M
Enterprise Value$36.90M
Total Cash (Recent Filing)$2.24M
Total Debt (Recent Filing)$10.51M
Price to Earnings (P/E)―
Beta1.24
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding118,678,990
10 Day Avg. Volume220,736
30 Day Avg. Volume152,344
Financial Highlights & Ratios
PEG Ratio1.06
Price to Book (P/B)1.70
Price to Sales (P/S)1.41
P/FCF Ratio34.86
Enterprise Value/Market Cap0.68
Enterprise Value/Revenue1.14
Enterprise Value/Gross Profit2.90
Enterprise Value/Ebitda8.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Gross And Operating MarginsGross margin improvement to ~42% and positive EBIT/EBITDA margins indicate the business is moving from volume-driven losses toward structurally healthier unit economics. Sustained operating profitability supports reinvestment in cultivation and retail, cushioning regulatory/price swings and improving long-term cash generation.
Positive Free Cash FlowGenerating positive operating and free cash flow despite net losses shows core operations convert revenue to cash. This durable cash productivity can fund working capital and modest capex, reduce external financing needs, and provide a runway to scale operations or invest in retail/processing efficiencies over the next several quarters.
Moderate Leverage And Equity CushionA debt-to-equity near 0.41 and a sizable equity base relative to assets indicate manageable leverage for a capital-intensive cannabis operator. This balance-sheet cushion reduces bankruptcy risk, supports licensing/compliance needs, and gives flexibility for staged investments in cultivation and retail expansion without immediate refinancing pressure.
Bears Say
Persistent Net LossesOngoing net losses and negative ROE signal the firm is not yet translating operating gains into bottom-line profitability. Sustained losses erode retained earnings, limit capacity for dividends or buybacks, and constrain strategic investments unless profitability is restored, presenting a multi-quarter risk to capital structure improvement.
Flat-to-declining Revenue TrendA TTM revenue decline of ~2.3% highlights top-line fragility in a competitive state market. Weak or negative revenue growth limits operating leverage benefits from improved margins, hinders scale economics in cultivation and retail, and makes financial outcomes more sensitive to pricing pressure or demand shifts over the next several quarters.
Weak Cash Coverage Of DebtAlthough cash flow is positive, a ~15% FCF decline and an operating-cash-to-debt ratio around 0.23 show limited ability to rapidly de-lever. If margins or sales deteriorate, the company could face constrained liquidity, reduced strategic optionality, and increased refinancing risk, which is material for a regulated cannabis operator.
CXXIF FAQ
What was C21 Investments Inc’s price range in the past 12 months?
C21 Investments Inc lowest stock price was $0.14 and its highest was $0.54 in the past 12 months.
What is C21 Investments Inc’s market cap?
C21 Investments Inc’s market cap is $53.94M.
When is C21 Investments Inc’s upcoming earnings report date?
C21 Investments Inc’s upcoming earnings report date is Aug 14, 2026 which is in 45 days.
How were C21 Investments Inc’s earnings last quarter?
C21 Investments Inc released its earnings results on Jun 11, 2026. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
Is C21 Investments Inc overvalued?
According to Wall Street analysts C21 Investments Inc’s price is currently Overvalued.
Does C21 Investments Inc pay dividends?
C21 Investments Inc does not currently pay dividends.
What is C21 Investments Inc’s EPS estimate?
C21 Investments Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does C21 Investments Inc have?
C21 Investments Inc has 118,678,990 shares outstanding.
What happened to C21 Investments Inc’s price movement after its last earnings report?
C21 Investments Inc reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.174%.
Which hedge fund is a major shareholder of C21 Investments Inc?
Currently, no hedge funds are holding shares in CXXIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
C21 Investments Inc
C21 Investments Inc. operates as a comprehensive enterprise within the cannabis sector, handling the cultivation, processing, distribution, and retail of consumer goods derived from cannabis and hemp throughout the United States. Its diverse product lineup includes both pre-packaged and bulk cannabis flower, vaporizer cartridges, concentrated extracts, edible products, pre-rolled joints, liquid tinctures, and topical applications. In addition, the company provides payroll administration and employee benefits solutions. Originally incorporated in 1987, the firm rebranded to C21 Investments Inc. in November 2017, having previously operated under the name Curlew Lake Resources Inc. Its primary corporate headquarters are situated in Vancouver, Canada.
Technical Analysis
Jushi Holdings
―
Auxly Cannabis Group
―
Leef Brands
―
Charlotte's Web Holdings
―
Planet 13 Holdings
―
Ownership Overview
84.55% Insiders
0.06% Other Institutional Investors
15.39% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---







